Modified-Release Formulation Strategies
Overview
CRDMO services that enable modified-release dosage forms to get to market. Fast.
Quotient Sciences capabilities for modified-release span the entire development pathway, from candidate development through to commercialization, reducing development risks and simplifying the supply chain for our customers. By taking a unique, integrated approach that is tailored to each program, we provide optimal results for our customers in the most efficient and cost-effective manner, getting new medicines to patients faster.
Modified-release format | Objective | Formulation technology |
---|---|---|
Gastro-retention |
| Swellable tablets (monolithic, bilayer, trilayer) |
Gastro-resistant |
| Enteric-coated tablets or capsules |
Sustained or extended release |
| Matrix tablets, coated tablets, or multiparticulates |
Targeted or controlled delivery |
| Tablets, capsules, or multiparticulates |
Biphasic release |
| Bilayer tablets or multiparticulates |
Pulsatile release |
| Bilayer tablets or multiparticulates |